ALYSSA MOORE: Open Payments
NPI 1093127615 · HOGANSBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,435 in 65 payments from 20 companies in 2025. Trend: 2023 $97 · 2024 $357 · 2025 $1,435
Food & beverage: $1,435
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $266 |
| Axsome Therapeutics, Inc. | 14 | $246 |
| ABBVIE INC. | 13 | $227 |
| Novo Nordisk Inc | 4 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Lundbeck LLC | 3 | $60 |
| PFIZER INC. | 2 | $46 |
| Exact Sciences Corporation | 2 | $45 |
| Ardelyx, Inc. | 2 | $42 |
Products named: Auvelity, FARXIGA, UBRELVY, CAPLYTA, Wegovy, REXULTI, QULIPTA, Ozempic.
Industry payments across NY — which companies pay providers there.
